These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38803418)

  • 1. The purpose and effectiveness of doping testing in sport.
    Lauritzen F; Solheim A
    Front Sports Act Living; 2024; 6():1386539. PubMed ID: 38803418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intelligence-based doping control planning improves testing effectiveness: Perspectives from a national anti-doping organisation.
    Lauritzen F; Holden G
    Drug Test Anal; 2023 May; 15(5):506-515. PubMed ID: 36582051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doping Prevalence among U.S. Elite Athletes Subject to Drug Testing under the World Anti-Doping Code.
    Davoren AK; Rulison K; Milroy J; Grist P; Fedoruk M; Lewis L; Wyrick D
    Sports Med Open; 2024 May; 10(1):57. PubMed ID: 38763945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidoping Science: Important Lessons From the Medical Sciences.
    Simon P; Neuberger EW; Wang G; Pitsiladis YP
    Curr Sports Med Rep; 2018 Oct; 17(10):326-331. PubMed ID: 30300193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sport, Society, and Anti-Doping Policy: An Ethical Overview.
    Bloodworth AJ; McNamee M
    Med Sport Sci; 2017; 62():177-185. PubMed ID: 28571026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of performance-enhancing substances (doping) by athletes in Saudi Arabia.
    Al Ghobain M
    J Family Community Med; 2017; 24(3):151-155. PubMed ID: 28932159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A call for policy guidance on psychometric testing in doping control in sport.
    Petróczi A; Backhouse SH; Barkoukis V; Brand R; Elbe AM; Lazuras L; Lucidi F
    Int J Drug Policy; 2015 Nov; 26(11):1130-9. PubMed ID: 26094122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of emerging patterns of drug misuse in sports via wastewater monitoring: A mini-review and potential strategies.
    Chang WC; Hsu MC; Liao PC
    Environ Pollut; 2023 Sep; 333():122087. PubMed ID: 37348696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The UK Sport perspective on detecting growth hormone abuse.
    Stow MR; Wojek N; Marshall J
    Growth Horm IGF Res; 2009 Aug; 19(4):375-7. PubMed ID: 19487144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative medicine and doping in sports.
    Koh B; Freeman L; Zaslawski C
    Australas Med J; 2012; 5(1):18-25. PubMed ID: 22905051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doping control, providing whereabouts and the importance of privacy for elite athletes.
    Valkenburg D; de Hon O; van Hilvoorde I
    Int J Drug Policy; 2014 Mar; 25(2):212-8. PubMed ID: 24462318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete.
    Kintz P
    J Pharm Biomed Anal; 2022 Jan; 207():114433. PubMed ID: 34715583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Banned substances and their incidence: A retrospective view of the national laboratory of prevention and doping control of Mexico.
    Mercado Soberanes K; Camacho Frías E; Rodríguez Balandrán L; Rodríguez Fermán ME; Mendoza Méndez N; Velasco-Bejarano B
    Adicciones; 2019 Jul; 31(3):201-211. PubMed ID: 30059594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of doping control test results in individual and team sports from 2003 to 2015.
    Aguilar-Navarro M; Muñoz-Guerra J; Del Mar Plara M; Del Coso J
    J Sport Health Sci; 2020 Mar; 9(2):160-169. PubMed ID: 32099724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
    Morente-Sánchez J; Zabala M
    Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.